Clostridium perfringens Enterotoxin Elicits Rapid and Specific Cytolysis of Breast Carcinoma Cells Mediated through Tight Junction Proteins Claudin 3 and 4

American Journal of Pathology

Volumn 164, Issue 5, 2004, Pages 1627-1633

  Kominsky, Scott L ^a   Vali, Mustafa ^a   Korz, Dorian ^a   Gabig, Theodore G ^c   Weitzman, Sigmund A ^d   Argani, Pedram ^b   Sukumar, Saraswati ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NW University Medical School ^*  (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 3; CLAUDIN 4; ENTEROTOXIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TIGHT JUNCTION; WESTERN BLOTTING; XENOGRAFT;

EID: 1942501592     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63721-2     Document Type: Article

References (23)

1. McClane BA, Hanna PC, Wnek AP: Clostridium perfringens enterotoxin. Microb Pathog 1988, 4:317-323
2. Sarker MR, Carman RJ, McClane BA: Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol 1999, 33:946-958
3. McClane BA: The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001, 39:1781-1791
4. McClane BA, McDonel JL: The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in Vero cells. J Cell Physiol 1979, 99:191-200
5. Horiguchi Y, Uemura T, Kozaki S, Sakaguchi G: The relationship between cytotoxic effects and binding to mammalian culture cells of Clostridium perfringens enterotoxin. FEMS Microbiol Lett 1985, 28:131-135
6. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N: Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997, 272:26652-26658
7. Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999, 96:511-516
8. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998, 141:1539-1550
9. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N: Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 1997, 136:1239-1247
10. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S: Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000, 476:258-261
11. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287
12. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM: Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001, 121:678-684
13. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001, 61:7878-7881
14. Bergstraesser LM, Weitzman SA: Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res 1993, 53:2644-2654
15. Ryu B, Jones J, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, Kern SE: Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002, 62:819-826
16. Nacht M, Ferguson AT, Zhang W, Petroziello JM, Cook BP, Gao YH, Maguire S, Riley D, Coppola G, Landes GM, Madden SL, Sukumar S: Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. Cancer Res 1999, 59:5464-5470
17. Skjelkvale R, Uemura T: Experimental Diarrhoea in human volunteers following oral administration of Clostridium perfringens enterotoxin. J Appl Bacteriol 1977, 43:281-286
18. Gabizon A, Chemla M, Tzemach D, Horowitz AT, Goren D: Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. J Drug Target 1996, 3:391-398
19. Chiba M, Hanes J, Langer R: Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. Biomaterials 1997, 18:893-901
20. Wallace FM, Mach AS, Keller AM, Lindsay JA: Evidence for Clostridium perfringens enterotoxin (CPE) inducing a mitogenic and cytokine response in vitro and a cytokine response in vivo. Curr Microbiol 1999, 38:96-100
21. Martinez-Palomo A: Ultrastructural modifications of intercellular junctions between tumor cells. In Vitro 1970, 6:15-20
22. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM: Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20:1425-1431
23. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S: Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999, 147:195-204